ArticleCancers2022

Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy.

Leslie Cuellar-Vite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.